| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.27 | 0.4 |